key: cord-0318040-mkxiia80
authors: Peters, Joshua M.; Blainey, Paul C.; Bryson, Bryan D.
title: Consensus transcriptional states describe human mononuclear phagocyte diversity in the lung across health and disease
date: 2020-08-07
journal: bioRxiv
DOI: 10.1101/2020.08.06.240424
sha: c2d8f3820b0dd1d302d0d0cfb0943208bc59b5d4
doc_id: 318040
cord_uid: mkxiia80

Monocytes, dendritic cells, and macrophages, commonly referred to as mononuclear phagocytes (MNPs), are innate immune cells capable of adopting diverse homeostatic and pathogenic phenotypes. Recent single-cell RNA-sequencing studies across many diseases in the lung have profiled this diversity transcriptionally, defining new cellular states and their association with disease. Despite these massive cellular profiling efforts, many studies have focused on defining myeloid dysfunction in specific diseases without identifying common pan-disease trends in the mononuclear phagocyte compartment within the lung. To address these gaps in our knowledge, we collate, process, and analyze 561,390 cellular transcriptomes from 12 studies of the human lung across multiple human diseases. We develop a computational framework to identify and compare dominant gene markers and gene expression programs and characterize MNP diversity in the lung, proposing a conserved dictionary of gene sets. Utilizing this reference, we efficiently identify disease-associated and rare MNP populations across multiple diseases and cohorts. Furthermore, we demonstrate the utility of this dictionary in characterizing a recently published dataset of bronchoalveolar lavage cells from COVID-19 patients and healthy controls which further reveal novel transcriptional shifts directly relatable to other diseases in the lung. These results underline conserved MNP transcriptional programs in lung disease, provide an immediate reference for characterizing the landscape of lung MNPs and establish a roadmap to dissecting MNP transcriptional complexity across tissues.

Monocytes, dendritic cells, and macrophages represent a group of innate immune cells commonly referred to as the mononuclear phagocyte system (MPS) (Guilliams et al., 2014; Jenkins and Hume, 2014) . These cells are derived from either fetal, yolk sac, or adult hematopoietic progenitor cells. These cells are responsible for a range of critical functions, such as phagocytosis of foreign bodies, presentation of antigens, cytokine secretion, and tissue maintenance. (Blériot et al., 2020; Nutt and Chopin, 2020) . To perform these functions, these cell types execute diverse and distinct transcriptional programs in response to local and systemic cues (Jaitin et The diversification of macrophages across tissue niches has been defined by specific transcription factors, chromatin architecture, and gene expression programs (Blériot et al., 2020; Lavin et al., 2014) . However, the diversification within tissue niches has been a target of more recent work, focusing on four main driving signals: origin, the local microenvironment and its immune state, and time (Blériot et al., 2020) . The lung is one such tissue niche containing a dynamic MNP population, including various resident macrophage populations, in addition to monocytes, recruited macrophages, and a host of dendritic cell subsets. Local macrophage populations can be replenished by blood monocytes in mice, which can progressively differentiate and acquire macrophage lineage and lung transcriptional markers Misharin et al., 2017) . The remodeling of the lung myeloid compartment as a whole is a recurring theme across lung diseases based on conventional markers (Baharom et al., 2017) . Most recently, large shifts in MNP populations have been described in COVID-19 (Liao et al., 2020) . However, the conserved and distinct aspects of this remodeling has not been fully explored.

Single-cell RNA-sequencing (scRNA-seq) has been used to profile millions of cells across human tissues and diseases, providing the opportunity to better define the complex phenotypes MNPs can occupy across health and disease (Svensson et al., 2019) . Broadly, numerous studies have identified unique monocyte, dendritic cell, and macrophage subsets associated with various tissue and sample classifications (Jaitin et (Laughney et al., 2020) , and chemokine-expressing macrophages (Zilionis et al., 2019) . Moreover, two recent studies compared MNP populations between humans and mice in great detail, showing broad correspondence between states but caution when identifying more specific states and genes (Leach et al., 2020; Zilionis et al., 2019) . While these studies have reinforced intra-niche diversity, the similarities and differences of the niche between diseases and cohorts remains unexplored.

To address the aforementioned gaps in our knowledge, here we harmonize consensus transcriptional signatures across 12 studies spanning 149 donors in order to advance our nomenclature and understanding of myeloid diversity. Utilizing two complementary methods, we identify conserved gene sets describing discrete cell states and more continuous gene programs, observing similar MNP populations in multiple cohorts and diseases. We capture both established MNP populations, such as blood monocytes, tissue-resident macrophages, and plasmacytoid dendritic cells, while also providing additional support of emerging signatures, such as intermediate, fibrotic, and chemokine-expressing macrophages states. We use this reference to dissect disease-associated trends in cancer, interstitial lung disease, and viral infection, highlighting efficient interrogation, interpretation, and support of lung MNP scRNA-seq profiles in the context of many diverse studies. This reference can be utilized similarly to common enrichment databases, but offers transparent sources and focuses on consistent, highly-detected genes in single-cell technologies. Our results establish a high-dimensional transcriptional reference for MNPs revealing the drivers of transcriptional heterogeneity in the lung and enable rapid contextual description of published and new data.

To analyze the lung MNP diversity, we obtained, processed, and annotated cellular profiles across 12 studies and 149 donors split across 160 technical batches. These samples profile idiopathic pulmonary fibrosis, non-small cell lung cancer, and systemic sclerosis-associated interstitial lung disease, among others (Table S1 and S2). We only included droplet-based single-cell RNA-sequencing technologies. To maintain the integrity of disease-specific effects within each dataset, we split the count matrices into healthy and disease count matrices, creating 18 total datasets representing the expression per gene per cell for each cohort of samples. Count matrices were processed using a semi-automated standardized pipeline, applied consistently to all datasets to ensure uniform computational transformations ( Figure 1A , S1A-S1C, Methods ) (Germain et al., 2020; Hie et al., 2020; Stuart et al., 2019) . First, we identified high-quality cells by filtering on technical metrics such as library size and percentage of mitochondrial reads. Significant batch effects were observed in all datasets, so we employed Harmony to correct for these effects in the PCA-generated low-dimensional space, which was used for downstream clustering and visualization only (Korsunsky et al., 2019; Traag et al., 2019) . We found that the proportion of variance explained by principal components was similar across datasets ( Figure S1D ), which may be expected due to the similar cellular populations. After this initial pre-processing, we sought to broadly annotate cell populations and identify monocytes, dendritic cells, and macrophages.

We used multiple, complementary procedures to annotate clusters, including inspecting differentially-expressed genes, classifying cells using the immunoStates expression reference (Vallania et al., 2018) , and scoring cells based on a recent healthy lung atlas (Travaglini et al., 2019) . To score cells, we extracted the top 20 defining genes (e.g. SFTPC for alveolar epithelial cells, COL1A1 for lipofibroblasts, MS4A1 for B cells, and S100A8 for classical monocytes) from each major cell type defined in this atlas. These scores represent the expression of the gene set above baseline expression ( Figure S1E ) (Tirosh et al., 2016) . To annotate clusters in an unsupervised manner, we utilized a voting procedure by assigning each cell a class label (e.g. Immune), subclass (Lymphocyte), and cell type label (e.g. B cell) based on the maximum score. Clusters were broadly annotated based on which assigned cell types were most frequent ( Figure S1F ), providing both a cluster annotation and a measure for the strength of that annotation.

To specifically identify clusters representing MNPs, we calculated a total MNP score for each cell, representing the difference between all MNP and all non-MNP scores. We defined a threshold score from this bimodal distribution by fitting two Gaussian distributions to these scores ( Methods ). Using this threshold, we extracted high-confidence clusters based on a median MNP score above threshold and a low frequency of non-MNP cell labels from the voting procedure. These clusters were processed and filtered in a semi-supervised manner to ensure high-quality MNP profiles based on all three metrics described here ( Methods ). Retained MNP clusters consist of cells classified as MNPs by Bayesian classifiers, show high and broad expression of previously published lung MNP markers, and are not defined by technical or non-MNP gene markers. After filtering, these cells were again reprocessed. This procedure produced concordant annotations with available, published annotations ( Figure S1G ). Overall, following gating and quality control filters, we analyzed 180,629 MNP scRNA-seq profiles, out of 561,390 total profiles, from 160 batches, 149 donors, and 12 studies ( Figure S1H ). We next sought to define a signature of MNPs built using single-cell RNA sequencing data that was robust across multiple datasets. By determining the most predictive genes for each MNP cluster versus all non-MNP cells, we defined a 20-gene signature that performed well in broadly classifying MNPs (AUC range 0.87-0.996 based on MNP annotation described previously) ( Figure 1B and 1C ). This signature included well-known mononuclear phagocyte markers, such as the MHC Class II molecules (HLA-DRA, HLA-DRB1, CD74) and recently identified markers from purified populations (TYROBP, FCER1G) (Dang et al., 2020) , as well as genes associated with other various functions, such as iron regulation (FTH1, FTL), complement (C1QA, C1QB), and lysosomal processing (CTSS, CTSB, LYZ, PSAP). ACP5 was also identified, which encodes a critical regulator of osteopontin (SPP1), which has been implicated in lung cancer and fibrosis ( Figure 1C ) (Kim et al., 2020; Reyfman et al., 2019) . MNPs represented a large proportion of leukocytes in each technical batch, but varied widely across samples ( Figure 1D ).

We next sought to broadly delineate the dominant highly variable genes underpinning diversity within these cell populations. Single-cell analyses typically leverage this subset of genes to focus on the most differentiating signals and reduce noise from uninformative genes. Consistent, variable genes represent critical molecular features responsible for, or a consequence of, intra-tissue cellular diversity. We identified a set of 3,665 consensus highly variable genes that underpin the heterogeneity in the lung MNP compartment ( Figure 1E and Table S3 ). These genes included well-established immunological markers and targets, such as IDO1, CXCL10, CCR7, and FOLR2 as well as less canonical genes FABP4, CHIT1, RBP4, SERPINB2, SPP1, SEPP1, and AREG. These genes should be studied further for their role in shaping MNP population structure. Robust, highly variable features within the MNP compartment in the lung could be a consequence of the underlying diversity or have a role in creating that diversity. Gene set enrichment of these consensus variable genes using GO Biological Process database revealed a diversity of functional associations related to the host of roles MNPs perform, most notably in angiogenesis, metabolic homeostasis, and mechanical extracellular interactions (Okabe and Medzhitov, 2016) . Indeed, the enrichment of a diverse functional set suggests that the transcriptional diversity is indicative of the many functions MNPs perform, supportive of the "variation is function" hypothesis (Dueck et al., 2016) .

Previous single-cell studies identified distinct transcriptional subpopulations in the lung MNP compartment, including macrophage, monocyte, and dendritic cell subtypes. To date, our understanding of the similarities across these subpopulations and studies remains limited. We first investigated whether distinct MNP transcriptional states were conserved and defined similarly across studies. To systematically compare cell states across each dataset, we established clusters, representing cells with similar expression profiles, and their respective gene markers within each dataset. Choosing the resolution of clustering remains an open and consistent challenge in single-cell RNA-sequencing analysis, so we focused on clustering cells at higher resolutions (creating more clusters with fewer cells) and retaining only clusters strongly described by multiple, highly-expressed genes based on various metrics such as the log fold change ( Methods ). This enabled us to capture the most distinctive, well-described cell states in each dataset (n = 295 total clusters, n = 267 with strong markers) described by up to 50 unique gene markers (Table S4) . For example, in two studies, Lambrechts et al. and Laughney et al., clusters emerged that were defined by strong inflammatory markers, such as CXCL10 and GBP1.

To determine the extent to which the diversity of the MNP populations are conserved across samples and diseases, we calculated the similarity of all states using the Jaccard distance, which represents the overlap of two gene lists (Jaccard distance = 0, perfect overlap) (Kinker et al., 2019) . We focused on 151 clusters that reached a minimum Jaccard index of 0.2 (Jaccard distance of 0.8) with at least one other cluster ( Methods ). These states were then hierarchically clustered to identify partitions of similar cell states defined by similar gene markers across various studies ( Figure 2B ). To determine the number of partitions, we defined a cutoff based on cluster distances and agreement with other methods, resulting in 21 partitions (Dynamic Tree Cutting, adjusted Rand index = 0.92 where 1 is perfect agreement; Cluster Bootstrapping, ARI = 0.94, Figure S2A -S2C) (Hennig, 2007; Langfelder et al., 2008) . These partitions contained clusters from multiple datasets (Shannon diversity between 1.5 and 2.5, Figure 2C ). Partitions with low diversity and reproducibility were filtered out and removed from downstream analyses (partitions 6, 14, 19, 21) . To further confirm the similarity of cell states within partitions, we utilized scmap , an unsupervised, high-performing classifier, to calculate a similarity metric for all pairwise combinations of all clusters (Kiselev et al., 2018) . Consensus partitions were significantly more similar than random equally-sized partitions (P < 0.001, Figure S2D , Methods ). We define these distinct partitions as consensus markers denoted as "M[X]" where X is an arbitrarily assigned number ( Figure S2E , Table S5 ).

We sought to define a conserved set of marker genes describing these partitions. To define these gene markers, we utilized the auROC metric which provides a relative indication of how well expression of specific genes signifies a specific cell state as defined by cluster membership (auROC = 1, perfect classifier, Figure 2D ). This revealed highly concordant marker genes within partitions, both confirming the consensus cell states as well as highlighting dominant signatures defining heterogeneity in the MNP compartment. As expected, we found prominent signatures of more familiar signatures, such as replicating cells (H2AFZ+, M2), CD14+ monocytes (S100A9+, M20), CD1C+ dendritic cells ( Enrichment of these gene sets using the Reactome Pathway database highlights a wealth of distinct functional processes ( Figure 2E ), owing to the diversity in cellular states identified. M7 and M15 are similarly associated with interferon signaling, although M7 is enriched for IFNγ signaling versus antiviral signaling in M15. M18, comprising apolipoprotein and lipid-associated genes, is enriched for sphingolipid processes suggesting a role for these molecules in population diversity. As expected, dendritic cell-like states were enriched for MHC Class II presentation and T-cell signaling (M11, M16, M17). Projection of these consensus cell states and their underlying populations using UMAP visualizes and reinforces this transcriptional state landscape ( Figure S2F ) seen in the MNP compartment. Indeed, projection of the auROC values for each contributing state and the resulting consensus states reveals highly distinct and coherent groups ( Figure S2G ). Overall, these consensus cell states, defined by robust, consistent genes, broadly define the diversity of the MNP population in a large cohort of lung samples.

Given the transcriptional spectrum seen in the mononuclear phagocyte compartment ( Figure  S3A ), we utilized an orthogonal approach to capture more continuous gene expression programs (GEPs). These GEPs aim to capture coregulated genes that describe cellular behavior both within and across cell types, such as a type I interferon response or general response to stress. Non-negative matrix factorization (NMF) has been established in single-cell RNA-sequencing analysis to identify gene expression programs descriptive of cellular identity and activity (Kinker et al., 2019; Kotliar et al., 2019; Welch et al., 2019) . Thus, by comparing GEPs across datasets, we aimed to identify consensus GEPs which consistently describe variation in the MNP compartment. We combined two previous approaches, consensus NMF and integrative NMF, to define 20 consensus, integrated factors representing GEPs ( Figure 3A ). In this approach, we perform integrative NMF across batches many times to generate robust batch-agnostic GEPs and utilize the top 5% contributing genes to each GEP for comparisons Using the same approach described for markers, we identify 23 initial partitions, resulting in 20 partitions after inspection and filtering (Dynamic Tree Cutting, ARI = 0.97, Cluster Bootstrapping, ARI = 0.88, Figure 3B , Figure S3B -S3D). Similarly, passing partitions are highly diverse, comprising program gene sets from many datasets ( Figure 3C ). To define a set of genes for each partition, we selected the top 50 genes with the highest median contribution to the GEPs within the partition ( Methods ). We define these consensus program gene sets as "P[ X ]" where X is an arbitrary assigned number (Table S6) . We compared these consensus programs to the previously defined consensus markers, revealing unique concordance between pairs of gene sets, such as P4-M1 and P2-M9 ( Figure 3D ). Some gene sets also show redundant overlapping, reflecting the similarity seen between certain gene sets, such as the monocyte-like marker sets defined by P1 and M3/12/20. Interestingly, P13 shows distinct similarity with M20, representing inflammasome-related genes IL1B and NLRP3. While P9 is similar to M7 and M15, P19 shows strong similarity with just M7, due to CXCL10, CXCL11, and GBPs. These gene sets provide corresponding descriptions of dominant cellular states and their underlying gene programs in the lung MNP compartment in health and disease.

Using the loadings of each gene for each GEP which represent the genes' importance in that GEP, we visualized the programs from each dataset, producing an embedding with no discernable batch effects ( Figure 3D and 3F). Programs that clustered together based on overlap of the most-defining genes also clustered distinctly within the embedding, supporting the consensus partitions. Moreover, these consensus GEPs are distinctly defined by the median gene contributions ( Figure 3G ), highlighting both the congruence of dominating genes in each GEP. This supports the ability to represent and analyze cellular variation from disparate datasets as GEPs derived from NMF (Welch et al., 2019) .

Inspection and enrichment of the consensus programs produces similar pathways to the consensus markers, but also includes enrichment of lipid-associated processes in P10 (APOC1, APOC2, LIPA, and TREM2) and P11 (FABP3, FABP4, FFAR4, LPL, SCD). Moreover, we see the appearance of P15 associated with the heat shock protein response and P14 associated with the metal ion response. P13 is enriched for chemokine expression and GPCR signaling, described by a host of immunoregulatory genes including CCL3, IL8, IL1B, IL6, NFKB1, and TNFAIP3. Comparison to conventional M1 and M2 signatures suggests moderate correlation between signature scores (M1 with P9, P13, P17, and P19 and M2 with P2, P8, and P10) ( Figure S3F ). This GEP-focused approach produced similar and additional gene sets compared to the marker-based approach, providing both support for these findings and expanding our definition of underlying molecular signatures. Overall, we present two concordant lists of marker and program gene sets which describe conserved, consistent transcriptional signatures in the lung mononuclear phagocyte compartment.

Dysregulation of MNPs has been hypothesized or shown to contribute to lung diseases included in this work (Reyfman et al., 2019; Zilionis et al., 2019), so we reasoned that we could leverage our consensus gene programs and markers to define the transcriptional programs associated with these cells during disease. We focused on comparing healthy and disease samples in a subset of 6 studies where this comparison was possible. We utilized a scoring approach that calculates a normalized expression for each gene set relative to a control gene set (Smillie et al., 2019; Tirosh et al., 2016) ( Methods ). To do so, we calculated scores for each gene set (either consensus markers or programs) across all healthy-and disease-derived cells by averaging the scaled expression for each gene and corrected for random expression of 30 control genes per gene in each gene set. This procedure generates scores for each gene set and cell, representing relative expression levels of each gene set. Across clusters within each dataset, scores for both marker and program gene sets were commonly expressed in a subset of clusters ( Figure S4A ). We captured expression changes using a mixed linear model on the most expressing clusters (top 2, Methods ), identifying both disease-and health-associated gene sets with variance across datasets ( Figure 4A ).

Using these scores, we focused on marker and program gene sets of interest. In one of the studies analyzed here, the authors identify that SPP1 expression is associated with idiopathic pulmonary fibrosis (Reyfman et al., 2019) . In our analysis, we uncovered a consensus cell state M10, which includes SPP1 and is statistically associated with disease in multiple fibrosis datasets ( Figure 4B ). This supports their findings and reveals additional candidate genes that are robust across multiple fibrosis datasets (Reyfman, Habermann, and Morse studies) that can be collectively studied in order to define and target the dysregulated pathways responsible for this state . Additionally, we see a shift in the 90th percentile of these scores between health and disease, further suggesting an overall shift in expression ( Figure 4B ). P17 represents an activated, migratory dendritic cell program typically expressed in a low fraction of cells (Maier et al., 2020) . In several datasets, these cells were not originally identified, so we utilized this program to identify the appearance of these rare cell types. We identified a fraction of cells in each dataset with a high P17 score and high DC likelihood based on the immunoStates reference, representing rare immunomodulatory dendritic cells ( Figure 4C Given the continuous and heterogeneous expression of these programs, we sought to further annotate the association of each gene set with the likelihood of each major mononuclear phagocyte cell type. We calculated the Pearson correlation of each program score with the likelihood across all cells, revealing a ternary spectrum between monocytes, macrophages, and dendritic cells ( Figure 4E ). Certain programs highly associated with monocyte or macrophage likelihood did contain canonical genes associated with these cell types, such as VCAN and APOE , respectively. However, many programs showed weaker association, suggesting that many MNP populations are not well-defined by classical definitions and may represent intermediate or transitory populations (Giladi et al., 2020; Rizzo et al., 2020) . Overall, we demonstrate broad utility of these gene sets to identify critical subsets, disease-associated trends, and broad population structure.

We next sought to demonstrate the utility of these consensus marker and gene sets and applied our scoring methodology to interrogate phagocyte dynamics in viral infection. Given the documented dysregulation of the myeloid compartment in COVID-19, we processed recently published profiles of bronchoalveolar lavage (BAL) samples from healthy, mild, and severe COVID-19 patients (Liao et al., 2020) . Viewing new profiles through this reference lens can enable quick access to biological interpretations and tools from previous work. We processed healthy, mild and severe patients separately and identified clusters using the same procedure described previously ( Figure 5A ).

We combined all cellular profiles and scored each cell by each consensus cell state and GEP gene set. Comparison of these scores across healthy, mild, and severe patients reveals broad increases in antiviral and inflammasome-associated GEPs identified previously in cancer, no shifts in fibrosis-related gene sets, and a decrease in GEPs describing both general and lipid-associated macrophage states ( Figure 5B ). M7 and P9, which similarly contain CD38, GBP1, and ISG15, and uniquely contain OAS1 and SOD2 respectively, show the highest expression in severe patients with a negative graded expression towards healthy samples. These cells expressing antiviral interferon-induced genes and lymphocyte chemokine genes have been previously annotated in cancer (Zilionis et al., 2019) and found to be associated with poor cancer prognosis. Conversely, we find that M5 (MARCO, MSR1+) and P11 (FABP3/4+), which describe an alveolar macrophage-like signature, are more prominent in healthy samples, supporting the observation of a shift away from a resident-dominated phagocyte population towards monocyte-associated populations expressing antiviral, inflammasome, and lymphotaxis-associated genes.

We next sought to describe the population dynamics within each condition using these consensus gene sets. We used an approach analogous to flow cytometry gating where we asked what proportion of cells were above a threshold. By determining the percentage of cells above an expression threshold, we quantified and visualized relative shifts in the population between each condition ( Methods ). Using this complementary approach, we find distinct infected versus healthy shifts (e.g. M7 and P9 described earlier), severe-only shifts (e.g. M3 -FCN1+, P19 -GBP5+), and graded shifts from healthy to severe (e.g. M4 -TCF4+ , M13 -PPARG+ , P7 -LILRB2+) ( Figure 5C ). Moreover, we see little expression and difference in gene sets associated with other macrophage populations (for example, M10 -SPP1+ and P2 -FOLR2+), suggesting an absence of these states. Lastly, we visualize the overall population scores of P1 (associated with monocyte likelihood) and P8 (associated with macrophage likelihood), highlighting a gradual shift of the population structure towards a monocyte-like dominated population ( Figure 5D ). Using this reference reveals specific identity and functional expression shifts in COVID-19 samples that can be directly contextualized in the context of broader lung populations.

These marker and program gene sets broadly describe phagocyte heterogeneity within the lung context. To generate candidate hypotheses for future studies which can define the underlying molecular factors for these gene sets, we performed enrichment analyses to nominate transcription factors, ligands, and receptors that may be associated with particular states.

Using the ARCHS4 transcription factor coexpression database in Enrichr, we identified several transcription factors that were significantly enriched in program gene sets versus background with prior literature support for their contribution to MNP and lung macrophage development To nominate potential ligand drivers of gene programs identified using NMF, we utilized NicheNet (Browaeys et al., 2020) . For each dataset, we set the receiver population as the top 2 expressing clusters for each gene set and the sending populations as all other cells. These populations were used to define expressed target and background genes, enabling us to collate an average ligand signal (Pearson correlation coefficients) for each program gene set ( Figure  6B Lastly, cell surface proteins provide a means to isolate specific subpopulations for powerful, targeted analyses. To identify candidate receptors that differentiate cell states or indicate activity of gene expression programs, we utilized a reference of cell surface proteins to calculate the Spearman correlation of receptor counts with program scores ( Figure 6C ). This enabled an unbiased look at receptors that may be positively or negatively correlated with these broad descriptors of MNP heterogeneity. As expected, we identify frequent strong correlations with MHC class II receptors with various programs (P8, P10) and canonical MNP markers, such as CD63, CD68, CD83, MERTK. This analysis also reveals additional markers that have been briefly investigated, but are not typically considered. These markers, such as CD109, CD276 (B7-H3), CD48, and LILRA5, may be useful in describing MNP variation in future investigations Overall, this collection of enrichment analyses provides an initial suggestion of which molecular factors could be responsible or associated with these reference cell states and programs.

A wealth of single-cell RNA-sequencing atlases have enabled unbiased profiling of cellular populations across conditions in the lung. The myeloid compartment within these atlases has received varying annotation and no harmonization across these findings has been attempted. Moreover, while specific pathogenic expression signatures have been identified in individual studies, the application and validation of these signatures in other cohorts has yet to be conducted. We hypothesized that standardized processing and comparison of genes describing cluster-specific and cluster-agnostic variation could reveal highly conserved gene sets. Our analysis across 12 studies generated 17 marker and 20 program consensus gene sets. This reference offers a robust, fast, and interpretable framework to decipher the single-cell transcriptional states of mononuclear phagocytes within the lung.

We first took a cluster-based approach to defining consensus signatures. By splitting each published cohort into disease and healthy samples, we sought to correct for batch effects without over-correcting any variation potentially attributable to disease biology. After identifying granular clusters and retaining defining markers, the broad comparison reveals strong partitions representing similarly-defined populations. Although coexpression patterns and nuances may vary between communities, we find consistent marker genes across all communities defined within a partition. A complementary approach using the gene expression programs (defined from NMF factors) reveals similar robust partitions defined by consistent genes. Visualization of clusters or programs across datasets by these scaled metrics describe the unique features of these populations with no identifiable dataset effects. This offers the ability to project new programs or marker gene sets into this low-dimensional embedding of community-defining gene sets. Additionally, this approach avoids complex integration methods across datasets from different cohorts and combines information across individual cell profiles which can be noisy.

The combination of these complementary marker-and program-based approaches underscored concordant results, supporting these gene sets as dominant features of variation within the lung MNP populations in both healthy and diseased samples.

Careful inspection of these consensus gene sets revealed expected descriptions of major cell populations, such as alveolar macrophages or CD14+ monocytes, and rarer subsets, such as a fibrosis-associated gene set containing previously validated genes (Reyfman et al., 2019) and an inflammation-associated gene set related to poor cancer prognosis (Zilionis et al., 2019) . These gene sets offer all the same utilities as the commonly used Gene Ontology resource, with the significant benefit of using well-detected and well-expressed genes captured using single cell technologies. We demonstrate these utilities by comparing gene set scores between healthy and disease samples, expanding upon the contribution of myeloid dysregulation to pulmonary diseases. M10 and P9 scores show an enrichment in disease samples in fibrosis and cancer, respectively, and should be utilized to further investigate the association of these genes and populations with disease. Moreover, identifying high P17-scoring cells enables the annotation of a rare immunoregulatory dendritic cell population recently described (Maier et al., 2020) . While several interesting trends exist amongst all these data, these trends were of particular interest. These scores enable the easy interrogation of critical expression trends, analogous to fluorescence intensity shifts in flow cytometry analyses. These gene sets provide more context to individual genes typically focused on for validation in studies. Identifying how genes associate and behave similarly across contexts can provide new insight into gene function and gene-gene relationships in cell populations. Moreover, given the continuous nature of the MNPs broadly in single-cell RNA-sequencing data, correlation of these programs with an alternative measure of cell type similarity (the maximum likelihood calculated from a purified bulk reference) provides additional context to the interpretation of cells expressing these gene sets above baseline.

We further utilize this reference to dissect single-cell expression dysregulation in COVID-19 bronchoalveolar lavage samples. While two groups have described distinct clusters and proportional shifts in their analyses, we focus on expression shifts related to these gene sets, since they can be quickly interpreted and related back to all the studies analyzed in this study. Most notably, the M7 and P9 gene sets related to activated myeloid expression are dramatically increased in disease samples versus M5 and P11 related to resident macrophage expression increased in healthy samples. When we define a general threshold across all samples and calculate the percentage of cells above threshold, robust shifts in population structure, consistent between individual donors, is revealed. Overall, these findings provide complementary insights into the dysregulation of the myeloid compartment during COVID-19 infection. While we see a shift towards monocytes and monocyte-derived phagocytes based on expression patterns, we also see increased expression of distinct markers and programs found in other disease pathologies. This provides evidence for the dysregulation of mononuclear phagocytes in COVID-19 pathogenesis, specifically the shift away from resident, lipid-associated macrophages to inflammatory (defined by type 1 IFNs and inflammasome genes) monocyte-like cells.

While many opportunities still exist for interrogating these datasets broadly, as well as the gene sets defined here, we performed enrichment analyses to identify potential molecular factors. These analyses provided a host of molecules for follow-up including MNP-related TFs (e.g. NR1H3, CREB5, PPARG, SP110), active ligands (e.g. ANXA1, AREG, JAG1, IL1RN, SCGB3A1), and descriptive markers (e.g. LILRA5, MERTK, MRC1, PLAUR, SERPING1, SIGLEC1, STAB1). Cataloging in vitro behavior of these molecules could enable improved interpretation of these suggestive enrichment, NicheNet, and correlative results.

This study focused on identifying consistent trends across lung datasets that were robustly codescriptive of similar states and similar gene expression programs. We recognize that more subtle patterns in gene expression or coexpression may be lost and look forward to addressing this in future work. These profiles are limited by the sensitivity and type of technology used to generate these profiles, as well as the availability of raw count matrices and associated metadata. While we focused on the lung here due to the available data, scientific interest, and unmet need, understanding how these findings translate to other tissues remains unknown. Extending this work to other tissues and datasets is a priority. This raises the important question of how similar MNP populations are intra-niche versus inter-niche. Lastly, we recognize the enormous potential of many tools developed by the single cell community and expect that the application of these tools to these data can provide additional complementary and novel insights into the transcriptional landscape of these cells.

Collectively, these analyses provide a reference to interrogate past and future transcriptomics of monocytes, dendritic cells, and macrophages. While this study is focused on lung datasets, we imagine that these findings will be a useful starting point for studying the MNP compartment in other tissues. Robust and diligent compilation of cellular states from in vivo data provides the opportunity to more efficiently co-opt biological insights across disease contexts within a tissue. As additional attention is given to re-engineering innate immune cells therapeutically, this reference can serve to annotate states, identify new cellular and gene-gene relationships, and repurpose myeloid-directed therapies across diseases. We imagine a tight feedback loop between well-controlled in vitro and model in vivo modulation of these states with deeply defined human in vivo states to attempt to better define the disease and tissue signals responsible for these states. The continued generation and integration of single cell transcriptomics will provide a map to deciphering clinically-relevant in vivo cellular states.

Lead Contact. Further information and requests for resources and reagents should be directed to Bryan Bryson ( bryand@mit.edu ).

This study did not generate new unique reagents. 

This study did not use any new experimental models or subjects.

Given the confusing and variable usage of common nomenclature used in transcriptomic analysis, we define terms used in this work for clarity. Within each dataset, we define clusters, or groups of cells that have similar transcriptomic profiles in low-dimensional space. We describe these clusters with marker genes ("markers" for short) which are expressed and detected at higher levels in these clusters. Additionally, we define gene expression programs (GEPs, "programs" for short), which are the factors of matrix W describing the loadings of each gene generated from non-negative matrix factorization algorithms. These are sometimes referred to as "metagenes". The generation and interpretation of these programs is described in previous work (Kotliar et al., 2019; Welch et al., 2019). Broadly, we refer to these markers or programs as gene sets. When we compare gene sets across datasets, we generate partitions, which represent larger groups of programs or markers defined from individual datasets. Ultimately, we describe these cellular populations and their transcriptional landscape by deriving both markers, derived from defining distinct clusters, and programs, derived from describing major axes of variation.

Raw count matrices were downloaded from respective published sources. To ensure the gene names were harmonized as best as possible, they were mapped to the Ensembl database using the R package EnsDb.Hsapiens.v86. Gene names that did not map were searched using an HGNC reference of gene names, aliases, and Ensembl IDs. Identified Ensembl IDs were reconverted to gene symbols. Any unidentified gene symbols were left as is. Raw matrices were then split based on disease status for applicable datasets. Seurat objects were populated with these raw data and processed using the same procedure. First, cells were filtered based on technical covariates: < 20% mitochondrial reads, <50% ribosomal reads, <5% hemoglobin reads, <5% heat shock protein family reads, > 200 UMI counts, > 100 genes detected. Filtered cells were then batch-corrected (based on broad observation of batch effects across datasets) using Harmony ( RunHarmony , Harmony R package) (Korsunsky et al., 2019) .

Downstream dimensionality selection 20 downstream dimensions were used for each dataset. Several heuristics were calculated for each dataset, including identification of elbow point based on maximum distance to the line between the first and last components' variance and the global maximum likelihood based on translated Poisson Mixture model using default parameters ( maxLikGlobalDimEst , intrinsicDimension R package). Visual inspection in combination with these methods suggested between 10 and 20 dimensions for each dataset. For ease and consistency, we utilized 20 Harmony-corrected dimensions for downstream clustering for all datasets. As others have suggested, we reasoned that this accurate or slight over-estimation of dimensionality would work well universally across datasets.

Cells were clustered using the Leiden algorithm using default parameters on the SNN graph utilizing the default parameters ( leiden_base_partition , leidenbase R package). First, resolution values were scanned for parameters that generated between 5 and 30 clusters. 30 resolution parameters were then tested between this range to identify the value that generated the maximal modularity. This value is then used for an additional 30 iterations to determine a final clustering. Any clusters with less than 10 cells were merged utilizing a modified implementation of GroupSingletons (Seurat R package). To assess the potential number of clusters and agreement with Leiden results, cells were also clustered using the walktrap algorithm ( cluster_walktrap , igraph R package). Clusters were renumbered based on the phylogenetic tree generated from averaged cluster expression and visualized using UMAP ( RunUMAP , Seurat R package).

Cell clusters were annotated using a semi-supervised approach. First, we extracted high-confidence marker genes defined in a published, comprehensive healthy lung atlas (differentially-expressed genes, average log FC > log(2), BH-adjusted P value < 1E-10, top 20 based on average log FC) (Travaglini et al., 2019). Each label was expanded into cell class labels (e.g. immune, epithelial) and subclass labels (e.g. myeloid, lymphocyte) manually. Each cell was scored based on each set of DEGs and assigned a class, subclass, and cell type label based on its maximum score. Clusters were then annotated using a voting approach. We found this voting approach to be superior to a threshold-based approach using Gaussian mixture models. Cycling cells were annotated using a similar scoring approach with the cell cycle genes defined in Seurat. Lastly, cells were classified using the immunoStates reference using a . This classifier generates a probability for each cell and each type in the immunoStates reference. We summed the results from each macrophage label or dendritic cell label to define the overall macrophage or dendritic cell likelihood.

Each dataset was initially classified using an automated approach, then reprocessed and cleaned with manual inspection of the measures described previously. First, we define a MNP score for each cell, which is the difference between the Travaglini scores for MNP cell types and non-MNP cell types. We then fit a Gaussian mixture model to this score and define an upper threshold of 2.5σ above µ. Clusters with a median score above this threshold were labeled as MP for the second round of classification. Cycling cells above this threshold were also included. Clusters that did not reach the median score threshold or contained more than 50% of other cell types (as classified by the maximum Travaglini score) were not MPs. This approach was repeated a second time on initial MP clusters. A second round of preprocessing and annotation revealed contaminating non-MP clusters that were manually inspected and removed. To aid in this procedure, a list of non-MP marker genes were defined for each dataset that included the highly predictive (auROC > 0.9) markers of non-MP clusters, lymphocyte receptor genes, and neutrophil genes (CSF3R, NAMPT). These excluded genes were used to identify contaminating clusters defined by excluded genes after reprocessing. These clusters are most likely due to ambient RNA distortion, suboptimal clustering, or unidentifiable heterotrophic doublets. While we cannot rule out the possibility that these cells are bona fide profiles representing a single cell expressing dominant and predictive transcripts of multiple clusters, further investigation is out of the scope for this study.

We utilized scmap (R package) to perform unsupervised projection of phagocyte clusters across all datasets, considering its speed and performance (Abdelaal et al., 2019; Kiselev et al., 2018) To compile a feature set for projection, we collated the marker genes for all clusters across all datasets and calculated their frequency and median auROC. We took the top 1000 genes that were identified in 4 or more datasets. These genes were then used to index each cluster from each dataset. The cluster indices (n = 290) were then projected to each dataset using a threshold of 0.3 to determine assignments. This procedure assigned a cluster label (or unassigned label) from each dataset for every cell within the query dataset. For each pair of query cells and reference dataset indices, we calculate the proportion of each reference assignment grouped by query clusters. This provides a voting-based similarity measurement for each pair of query and reference clusters. We sparsify these similarities by zeroing any proportions where the number of labeled cells is below 5 or the proportion is below 1%. We collate the similarities for each pair to generate a matrix of query clusters by reference clusters describing a complete bidirectional dictionary of cluster projections.

Filtered cells were clustered using the Leiden algorithm on the SNN graph, implemented in leidenbase (R package) utilizing the default parameters. First, resolution values were scanned for parameters that generated between 5 and 30 clusters. 30 resolution parameters were then tested between this range to identify the value that generated the maximal modularity. This value is then used for an additional 30 iterations to determine a final clustering. Any clusters with less than 5 cells were merged utilizing a modified implementation of GroupSingletons (Seurat R package). Clusters are then hierarchically clustered in the low-dimensional PCA space and renumbered for convenience. Mann-Whitney U and auROC testing is performed ( wilcoxauc , Presto R package) and the second-to-max log fold change (LFC) is calculated, which is the fold change between the top two expressing clusters. Clusters that fail to be defined by gene markers (LFC > 1.25, second-to-max LFC > 1.05, AUC > 0.5, BH-adjusted P value < 1E-3) are then merged with the nearest cluster. Clusters are not merged if they are to be merged with multiple clusters (a node in the hierarchical tree) or a cluster defined by more than 50 markers. This prevented merging of poorly defined clusters with well-defined clusters, which could increase noise in the markers.

To directly compare gene sets that define clusters or factors, we utilize the Jaccard distance, as described previously (Kinker et al., 2019) . We compute the symmetric Jaccard distance matrix and remove sets with no occurrences of a Jaccard similarity of more than 0.2. We perform agglomerative hierarchical clustering on this filtered Jaccard distance matrix and cut the tree to generate k partitions based on heuristic assessment of the within-sum-of-squares and silhouette plot across a range of potential k values. To assist in selection, we calculate a combined rank for each k by adding the sorted index of the within sum-of-squares and silhouette values and take the minimum as a suggestion for the minimal k . In practice, we set k on the higher end of potential values to generate more clusters and refine the partitions subsequently. For each partition, we then collate the original data (e.g. differential expression results, factor loadings) to generate consensus descriptions of each partition (see Methods sections Generation of consensus markers , Generation of consensus gene expression programs ). We admiringly acknowledge that, during the course of this study, a method proposing a similar workflow with favorable results was published (Gao et al., 2019) . This supports our approach and provides useful, additional bioinformatic tools for researchers.

Although attempted (not published), methods that integrate individual datasets are computationally prohibitive as cell population scales and are more difficult to interpret and validate, especially when looking at one cell type. By focusing on the easily interpretable Jaccard index and auROC metrics, we efficiently minimize study-specific effects and noise.

After generating partitions of cluster markers based on the Jaccard distances, the median AUC, median log FC, and number of contributing clusters for each gene was calculated. Resulting partitions were removed if they contained only 1 source dataset or were defined by gene families associated with technical covariates (see Preprocessing ). Partitions consisting of one dataset were also removed after inspection. less We then filtered genes that did not appear in at least a third of contributing clusters (minimum of at least 2) and then sorted these by descending median AUC. The top 50 genes were chosen to represent an efficient, consensus gene set that defines clusters across datasets. This Jaccard-based approach was validated using additional marker gene sets and scmap (R package).

Integrative non-negative matrix factorization was performed in LIGER as published (Welch et al., 2019) . For each dataset, the MPs were integrated by batch across 30 dimensions with k = 20 and λ=5. K was chosen based on previous procedures (see Downstream dimensionality. This produced a usage matrix, H, a shared factor matrix, W, and donor-specific factor matrices V. This procedure was executed 30 times for each dataset. These replicates were compiled to generate robust W matrices using a modified procedure from consensus NMF (Kotliar et al., 2019) . Briefly, all metagenes in all replicates (n = 600) were compiled into a single matrix and L2-normalized. The top 9 nearest neighbors were identified (ρ = 0.3). Factors beyond the 90th percentile of the average distance to the top 9 nearest neighbors were removed and the remaining factors were clustered on their loadings using K-Means (kmeans, stats) with 30 random starts to obtain 20 factor clusters. Grouped factors were compiled into a final set of factors by taking the median loadings. This consensus iNMF procedure generates a matrix W describing 20 donor-agnostic gene expression programs for each dataset used for downstream comparison.

Similar to generating consensus markers, factors were partitioned into groups using the procedure outlined previously (see Comparison and clustering of gene sets ). Factors were defined by the top 5% of genes based on the non-zero loadings. The Jaccard distance was calculated and clustered using agglomerative hierarchical clustering with the Ward method (hclust R package, stats R package). Consensus genes were compiled based on their frequency in at least a third of the factors within each partition. Additionally, median consensus loadings were computed from respective factors within each partition for visualization.

We scored gene sets to generate a new aggregate expression level corrected for background expression of each cell, as described previously (Smillie et al., 2019; Stuart et al., 2019; Tirosh et al., 2016) . In preprocessing, gene sets were scored using the AddModuleScore function in Seurat (R package). Downstream analyses utilized a modified version of this function in which scaled expression, not normalized expression, was used to aggregate the score. Briefly, gene sets were scored by aggregating the expression of each gene within the dataset minus the expression from control genes. For each gene, 30 control genes within the bin of expression (20 bins) for the gene of interest were selected.

After scoring cells for the broad expression of a gene set, we characterized the distribution of the scores amongst the cells of interest. We described the distribution of these scores as a bimodal mixture of Gaussian distributions ( normalmixEM , mixtools R package) after visual and statistically inspection (diptest, Pearson diagram) where distributions were typically right skewed or bimodal. Given the difficulty of inspecting and fitting accurate models for every dataset and score, we utilized bimodal Gaussian distributions to capture cells either in the upper quantile of gene set expression or cells describing the second mode. We determine a threshold based on 2σ above the minimum peak µ in the fitted Gaussian mixture model. We also used the 90th quantile to determine shifts in scores. To do so, we bootstrapped the scores 1000 times from each condition label of interest and calculated the summary statistic distribution to report.

We derived M1-like and M2-like signatures from Martinez et al. and calculated their scores as previously described (Martinez et al., 2006) . We report the Pearson correlation of these scores with program scores.

We utilized Enrichr (enrichR, R package) to perform gene set enrichment analysis on our findings (Kuleshov et al., 2016) . The ARCHS4, Reactome Pathway, and most recent GO databases were used (Ashburner et al., 2000; Lachmann et al., 2018) .

NicheNet was used to identify potential ligand-receptor activity within MNP populations, as outlined in the method vignettes (Browaeys et al., 2020) . We define sender and receiver populations, background and target gene sets, and potential ligands. NicheNet returns ligand activities based on target genes relative to background genes. Potential receptors are then identified from top ligands. In this application, we defined sender populations as all non-MNP cells. The receiving population was defined as cells in the top two clusters based on the gene set score of interest. The Pearson correlation coefficient and auROC is reported as a measure of suggested ligand activity.

To identify surface protein expression correlated with gene set expression, we calculated the Spearman correlation of receptor counts with gene set scores. Putative surface proteins were selected based on the Cell Surface Protein Atlas (Bausch-Fluck et al., 2015) .

J.M.P. and B.D.B were supported by grants R01A1022553 and R21DE026582. P.C.B. was supported by a Burroughs Wellcome Fund CASI Award. 

Non-MNPs , IGF1, CXCL12  CCR7, CCL19, CD200   HSD11B1, GGT5, OLFML3   CAMP, FABP4, GPD1   CLEC9A, SNX22, CCSER1   SLAMF9, TMEM45A, MT1H   IFI44, OAS2, IFIT1  SEPP1, TMEM37, FOLR2   CENPF, CCL8, IFIT2   IL1A, CCL3L3, CCL4L2  KIAA0101, NME1, BOLA3   PTGDS, ITM2C, DERL3  FSCN1, POGLUT1, 

Control Mild Severe P 9 P 1 9 P 1 3 P 1 5 P 1 P 7 P 1 4 P 1 6 P 1 7 P 2 P 2 0 P 4 P 1 2 P 1 8 P 6 P 5 P 1 0 P 8 P 3 P 1 1 ATF3  ATOH8  BATF2  BCL6  CD36  CEBPA  CREB5  CREBL2  DEPDC1  DEPDC1B  E2F8  EGR2  ELK3  ETV3  ETV3L  ETV7  EZH2  FLI1  FOSB  FOSL1  FOXC2  FOXL1  HIC1  HLA−DQB1  HLA−DRB3  HMGB2  IGHM  IKZF2  IKZF3  IRF2  IRF4  IRF8  JUN  KLF10  KNTC1  MAF  MAFB  MSC  MTF1  MXD1  NEUROG3  NFE2L2  NR1H3  NR4A2  NR4A3  PARP12  PAX5  PLEK2  PLEKHA4  PLXNC1  PPARG  RAD51  RUNX2  SOX18  SP110  SPIB  STAT1  STAT2  ZBP1  ZBTB32  ZNF467 ZNF697 ZNFX1 P 1 P 2 P 3 P 4 P 5 P 6 P 7 P 8 P 9 P 1 0 P 1 1 P 1 2 P 1 3 P 1 4 P 1 5 P 1 6 P 1 7 P 1 8 P 1 9 P 2 0

Consensus gene programs Transcription factor enrichment (ARCHS4) 10 R e y f m a n 2 0 1 9

Condition M 1 8 M 2 0 P 1 P 2 P 3 P 4 P 5 P 6 P 7 P 8 P 9 P 1 0 P 1 1 P 1 2 P 1 3 P 1 4 P 1 5 P 1 6 P 1 7 P 1 8 

A comparison of automatic cell identification methods for single-cell RNA sequencing data

Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis

Gene Ontology: tool for the unification of biology

Systems genetics identifies a macrophage cholesterol network associated with physiological wound healing

Human Lung Mononuclear Phagocytes in Health and Disease

A Mass Spectrometric-Derived Cell Surface Protein Atlas

Determinants of Resident Tissue Macrophage Identity and Function

NicheNet: modeling intercellular communication by linking ligands to target genes

Studying the mononuclear phagocyte system in the molecular age

Computational Approach to Identifying Universal Macrophage Biomarkers

Variation is function: Are single cell differences functionally important?

ClusterMap: compare multiple single cell RNA-Seq datasets across different experimental conditions

Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages

pipeComp, a general framework for the evaluation of computational pipelines, reveals performant single-cell RNA-seq preprocessing tools

Cxcl10 + monocytes define a pathogenic subset in the central nervous system during autoimmune neuroinflammation

New insights into the multidimensional concept of macrophage ontogeny, activation and function

Salmonella Persist in Activated Macrophages in T Cell-Sparse Granulomas but Are Contained by Surrounding CXCR3 Ligand-Positioned Th1 Cells

Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny

Single-cell RNA-sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis

Dendritic cell and macrophage heterogeneity in vivo

Cluster-wise assessment of cluster stability

Computational Methods for Single-Cell RNA Sequencing

Macrophage derived CXCL9 and CXCL10 are required for anti-tumor immune responses following immune checkpoint blockade

Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages

Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent Manner

Homeostasis in the mononuclear phagocyte system

Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma

Pan-cancer single cell RNA-seq uncovers recurring programs of cellular heterogeneity

scmap: projection of single-cell RNA-seq data across data sets

Fast, sensitive and accurate integration of single-cell data with Harmony

Identifying gene expression programs of cell-type identity and cellular activity with single-cell RNA-Seq

Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

ATF3 Is a Key Regulator of Macrophage IFN Responses

Massive mining of publicly available RNA-seq data from human and mouse

Phenotype molding of stromal cells in the lung tumor microenvironment

Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R

Regenerative lineages and immune-mediated pruning in lung cancer metastasis

Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment

Human and mouse transcriptome profiling identifies cross-species homology in pulmonary and lymph node mononuclear phagocytes

Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function

Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages

Single cell transcriptomics based-MacSpectrum reveals novel macrophage activation signatures in diseases

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived Cells

Interleukin-33 Signaling Controls the Development of Iron-Recycling Macrophages

scRNA-seq assessment of the human lung, spleen, and esophagus tissue stability after cold preservation

A conserved dendritic-cell regulatory program limits antitumour immunity

Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression

Specification of tissue-resident macrophages during organogenesis

Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution

Integrated single cell analysis of human lung fibrosis resolves cellular origins of predictive protein signatures in body fluids

Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation

Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span

Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis

Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity

Transcriptional Networks Driving Dendritic Cell Differentiation and Function

Tissue biology perspective on macrophages

iMAC: An interactive atlas to explore phenotypic differences between in vivo, ex vivo and in vitro-derived myeloid cells in the Stemformatics platform

Resolving the fibrotic niche of human liver cirrhosis at single-cell level

Single-cell connectomic analysis of adult mammalian lungs

An immune-cell signature of bacterial sepsis

Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis

Single-cell transcriptomic profiling maps monocyte/macrophage transitions after myocardial infarction in mice

Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages

Transcription factor Nr4a1 couples sympathetic and inflammatory cues in CNS-recruited macrophages to limit neuroinflammation

Macrophage plasticity and polarization: in vivo veritas

Intra-and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis

Comprehensive Integration of Single-Cell Data

A curated database reveals trends in single-cell transcriptomics

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq

From Louvain to Leiden: guaranteeing well-connected communities

A molecular cell atlas of the human lung from single cell RNA sequencing

Leveraging heterogeneity across multiple datasets increases cell-mixture deconvolution accuracy and reduces biological and technical biases

Macrophage PPARγ, a Lipid Activated Transcription Factor Controls the Growth Factor GDF3 and Skeletal Muscle Regeneration

Early Growth Response Gene-2 Is Essential for M1 and M2 Macrophage Activation and Plasticity by Modulation of the Transcription Factor CEBPβ

A cellular census of human lungs identifies novel cell states in health and in asthma

Single-Cell Multi-omic Integration Compares and Contrasts Features of

Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation

Profiling peripheral nerve macrophages reveals two macrophage subsets with distinct localization, transcriptome and response to injury

Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR article

Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species

We thank the Blainey and Bryson laboratory members for valuable discussions and feedback, the researchers who produced the data used in this study and the donors who provided samples for these data, and the developers of the following R and Python packages: Seurat, Harmony, LIGER, cNMF, and the tidyverse collection.

Habermann 2019 disease 1 Habermann 2019 disease 10 Habermann 2019 disease 11 Habermann 2019 disease 12 Habermann 2019 disease 13 Habermann 2019 disease 14 Habermann 2019 disease 15 Habermann 2019 disease 16 Habermann 2019 disease 17 Habermann 2019 disease 18 Habermann 2019 disease 19